ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 210717 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 210717; 2) Community: the network communities that were significantly associated with the response to NSC 210717; 3) Molecule: the relationships between components within communities and NSC 210717; 4) MDR: the compounds that were significantly associated with the NSC 210717.

NSC Compound Enrichment Correlation
NSC 734924 Null 0.0036112018156453 -0.084711357
NSC 759857 Clofarabine (USAN) 0.0036112018156453 0.40321861
NSC 651654 Null 0.0041574867185751 0.49327852
NSC 347217 Carbamic acid, [5-amino-1,2-dihydro-3-(2-naphthalenyl)pyrido[3,4-b]pyrazin-7-yl]-, ethyl ester, monohydrochloride 0.0045408171545557 0.36064542
NSC 741107 6-(3-Aminopropyl)-9-cyano-5,6-dihydro-3-nitro-5,11-dioxo-11H-indeno[1,2-c]isoquinoline Hydrochloride 0.0045408171545557 0.32209447
NSC 302991 Camptothecin Derivative 0.00581536684273141 0.48347086
NSC 382386 2,4-Imidazolidinedione, 3,3'-(1,6-hexanediyl)bis[5,5- diphenyl- 0.00581536684273141 0.0085005307
NSC 658093 Null 0.00581536684273141 0.35372099
NSC 711615 Null 0.00581536684273141 0.087824099
NSC 727284 2-Bromo-3-methoxy-6-(methylamino)-9,10-dihydrdo-9,10-[1,2]be nzenoanthracene-1,4,5,8-tetraone. 0.00581536684273141 0.096735203
Total:32  Current:3    [First] [Prev] [Next] [Last]